Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis
Identifieur interne : 003E09 ( Main/Merge ); précédent : 003E08; suivant : 003E10Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis
Auteurs : Andrew H. Evans [Australie] ; Helmut Butzkueven [Australie]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-03-15.
English descriptors
- KwdEn :
- Adult, Benserazide (adverse effects), Benserazide (therapeutic use), Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Female, Gambling (psychology), Humans, Impulse Control Disorders (chemically induced), Impulse Control Disorders (psychology), Levodopa (adverse effects), Levodopa (therapeutic use), Multiple Sclerosis (complications), Multiple Sclerosis (physiopathology), Restless Legs Syndrome (diagnosis), Restless Legs Syndrome (drug therapy), Restless Legs Syndrome (etiology).
- MESH :
- chemical , adverse effects : Benserazide, Dopamine Agonists, Levodopa.
- chemical , therapeutic use : Benserazide, Dopamine Agonists, Levodopa.
- chemically induced : Impulse Control Disorders.
- complications : Multiple Sclerosis.
- diagnosis : Restless Legs Syndrome.
- drug therapy : Restless Legs Syndrome.
- etiology : Restless Legs Syndrome.
- physiopathology : Multiple Sclerosis.
- psychology : Gambling, Impulse Control Disorders.
- Adult, Drug Therapy, Combination, Female, Humans.
Url:
DOI: 10.1002/mds.21303
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003C92
- to stream Istex, to step Curation: 003C92
- to stream Istex, to step Checkpoint: 001995
- to stream PubMed, to step Corpus: 002885
- to stream PubMed, to step Curation: 002885
- to stream PubMed, to step Checkpoint: 002857
- to stream Ncbi, to step Merge: 001A54
- to stream Ncbi, to step Curation: 001A54
- to stream Ncbi, to step Checkpoint: 001A54
Links to Exploration step
ISTEX:4C55FD144C16DECFF62E9710A038897C2EE4D66FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H." last="Evans">Andrew H. Evans</name>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4C55FD144C16DECFF62E9710A038897C2EE4D66F</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21303</idno>
<idno type="url">https://api.istex.fr/document/4C55FD144C16DECFF62E9710A038897C2EE4D66F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003C92</idno>
<idno type="wicri:Area/Istex/Curation">003C92</idno>
<idno type="wicri:Area/Istex/Checkpoint">001995</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Evans A:dopamine:agonist:induced</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17230484</idno>
<idno type="wicri:Area/PubMed/Corpus">002885</idno>
<idno type="wicri:Area/PubMed/Curation">002885</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002857</idno>
<idno type="wicri:Area/Ncbi/Merge">001A54</idno>
<idno type="wicri:Area/Ncbi/Curation">001A54</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A54</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Evans A:dopamine:agonist:induced</idno>
<idno type="wicri:Area/Main/Merge">003E09</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H." last="Evans">Andrew H. Evans</name>
<affiliation wicri:level="1"><country wicri:rule="url">Australie</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Melbourne Hospital, Parkville</wicri:regionArea>
<wicri:noRegion>Parkville</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Melbourne Hospital, Parkville</wicri:regionArea>
<wicri:noRegion>Parkville</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-03-15">2007-03-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="590">590</biblScope>
<biblScope unit="page" to="591">591</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4C55FD144C16DECFF62E9710A038897C2EE4D66F</idno>
<idno type="DOI">10.1002/mds.21303</idno>
<idno type="ArticleID">MDS21303</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Benserazide (adverse effects)</term>
<term>Benserazide (therapeutic use)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Gambling (psychology)</term>
<term>Humans</term>
<term>Impulse Control Disorders (chemically induced)</term>
<term>Impulse Control Disorders (psychology)</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Multiple Sclerosis (complications)</term>
<term>Multiple Sclerosis (physiopathology)</term>
<term>Restless Legs Syndrome (diagnosis)</term>
<term>Restless Legs Syndrome (drug therapy)</term>
<term>Restless Legs Syndrome (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Benserazide</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benserazide</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Impulse Control Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Gambling</term>
<term>Impulse Control Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<double doi="10.1002/mds.21303"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H." last="Evans">Andrew H. Evans</name>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4C55FD144C16DECFF62E9710A038897C2EE4D66F</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21303</idno>
<idno type="url">https://api.istex.fr/document/4C55FD144C16DECFF62E9710A038897C2EE4D66F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003C92</idno>
<idno type="wicri:Area/Istex/Curation">003C92</idno>
<idno type="wicri:Area/Istex/Checkpoint">001995</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Evans A:dopamine:agonist:induced</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H." last="Evans">Andrew H. Evans</name>
<affiliation wicri:level="1"><country wicri:rule="url">Australie</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Melbourne Hospital, Parkville</wicri:regionArea>
<wicri:noRegion>Parkville</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Neurology, Royal Melbourne Hospital, Parkville</wicri:regionArea>
<wicri:noRegion>Parkville</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-03-15">2007-03-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="590">590</biblScope>
<biblScope unit="page" to="591">591</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4C55FD144C16DECFF62E9710A038897C2EE4D66F</idno>
<idno type="DOI">10.1002/mds.21303</idno>
<idno type="ArticleID">MDS21303</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H" last="Evans">Andrew H. Evans</name>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="doi">10.1002/mds.21303</idno>
<idno type="RBID">pubmed:17230484</idno>
<idno type="pmid">17230484</idno>
<idno type="wicri:Area/PubMed/Corpus">002885</idno>
<idno type="wicri:Area/PubMed/Curation">002885</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002857</idno>
<idno type="wicri:Area/Ncbi/Merge">001A54</idno>
<idno type="wicri:Area/Ncbi/Curation">001A54</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A54</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Evans A:dopamine:agonist:induced</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.</title>
<author><name sortKey="Evans, Andrew H" sort="Evans, Andrew H" uniqKey="Evans A" first="Andrew H" last="Evans">Andrew H. Evans</name>
</author>
<author><name sortKey="Butzkueven, Helmut" sort="Butzkueven, Helmut" uniqKey="Butzkueven H" first="Helmut" last="Butzkueven">Helmut Butzkueven</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Benserazide (adverse effects)</term>
<term>Benserazide (therapeutic use)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Gambling (psychology)</term>
<term>Humans</term>
<term>Impulse Control Disorders (chemically induced)</term>
<term>Impulse Control Disorders (psychology)</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Multiple Sclerosis (complications)</term>
<term>Multiple Sclerosis (physiopathology)</term>
<term>Restless Legs Syndrome (diagnosis)</term>
<term>Restless Legs Syndrome (drug therapy)</term>
<term>Restless Legs Syndrome (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Benserazide</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benserazide</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Impulse Control Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Multiple Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Gambling</term>
<term>Impulse Control Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E09 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003E09 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:4C55FD144C16DECFF62E9710A038897C2EE4D66F |texte= Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis }}
This area was generated with Dilib version V0.6.23. |